#United States #Tampa #Elsevier #The Lancet #Conexiant

Conexiant and Elsevier: A New Era in Biomedical Research

Conexiant, a leading global healthcare media network, has recently announced a strategic partnership with Elsevier, a renowned provider of information databases, through a licensing agreement. This collaboration revolves around "The Lancet: Research in Context," a digital initiative that aims at broadening access to insightful research from The Lancet journals. This agreement aligns both organizations in their mission to advance clinical knowledge and connect healthcare professionals with crucial findings across ten therapeutic areas.

The Initiative's Framework

Launched recently, the initiative provides a focused platform that houses contextualized research articles tailored to various disease states. By doing so, it ensures that healthcare professionals are not only exposed to recent studies, but also understand the context surrounding these findings. This includes insights into prior evidence, the novel contributions of new research, and the potential implications for clinical practice and future research endeavors.

The primary areas of focus at the outset include non-small cell lung cancer, breast cancer, prostate cancer, and other critical diseases such as Alzheimer's and inflammatory bowel disease. Each therapeutic area will provide specific digital destinations coupled with e-newsletters and specialized engagement programs aimed at maximizing the utility and discoverability of the original Lancet articles.

Enhancing Clinical Engagement

The partnership is designed to deepen the engagement between healthcare professionals and the original research by creating a clear path back to the source material. By organizing globally authoritative research around key disease states, Conexiant and Elsevier will aid clinicians in better understanding vital findings, ultimately supporting more informed clinical decisions.

Charlie Lee, CEO of Conexiant, articulated the significance of this collaboration by stating, "This partnership represents another exciting step in our relationship with Elsevier and reflects exactly where we believe medical publishing is headed." He emphasized that by broadening accessibility to context-rich content, life sciences organizations could engage more effectively around critical clinical topics.

Research in Context: A Valuable Resource

The Research in Context framework has been a pivotal feature of The Lancet family since its introduction in 2005, specifically aimed at enhancing reader comprehension regarding new findings within the spectrum of existing evidence. Laura Hassink, Managing Director of Elsevier Journals, reiterated the importance of this initiative by noting that this partnership with Conexiant will enable a more extensive reach of context-rich content to specialized audiences, thus fostering deeper engagement and connection back to published articles.

Moving forward, the collaboration between Conexiant and Elsevier not only strengthens the existing relationship but also explores new avenues for contextual scientific communication, audience engagement, and licensed dissemination. This initiative is expected to redefine how scientific information can be communicated and made accessible to healthcare professionals, ensuring that they are well-equipped with the necessary knowledge to make informed decisions in their practices.

About the Partners

Conexiant: This global healthcare media and engagement network is known for its extensive relationships with over 190 medical societies and health organizations. They focus on connecting trusted clinical knowledge with healthcare practitioners worldwide to foster better clinical decisions and innovations in patient care.

Elsevier: As a global leader in advanced information solutions, Elsevier plays a critical role in aiding scientific and healthcare communities through its research and decision-support products. Their dedication to facilitating knowledge and information access aids in driving progress in various fields, including biomedical research and clinical practices.

Conclusion

The licensing agreement between Conexiant and Elsevier marks an essential development in the biomedical landscape. By creating a robust framework for the dissemination of research through the Research in Context model, the partnership seeks to enhance the understanding and application of scientific research in clinical settings, ultimately leading to improved patient care and health outcomes in the future.